Skip to main content
. 2020 May 20;12(5):466. doi: 10.3390/pharmaceutics12050466

Table 2.

In vitro data (IC50) using PrestoBlue assay on HT-29 cell line in a four-hour experiment. Phase transition temperature optimization of the liposomal formulation using the different w/w% 1,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine (DPPC) and hydrogenated soybean phosphatidylcholine (HSPC) mixtures (Table 1) for using heat treatment.

Liposome Formulation IC50 (µM) (RSD < 20%)
37 °C 38 °C 39 °C
LIPO1
HEAT RES LIPO
>40 >40 ~40
LIPO2 >40 >40 ~40
LIPO3
HEAT SENS LIPO
>40 >40 36.8
LIPO4 >40 30.9 15.5
LIPO5 >40 9.9 5.2
LIPO6 ~40 5.9 4.6